comparemela.com

Carol Horowitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medical Studies Are Too White How Science Is Working to Get Better Data

Get hands-on and learn all about the Lowcountry way of life at the Coastal Discovery Museum

Long Covid is said to affect white middle-aged women more – but data suggests otherwise

Mount Sinai Receives Landmark Gift from Royalty Pharma to Advance Health Equity

COVID proves clinical trials must proactively recruit people of color

COVID proves clinical trials must proactively recruit people of color Jo Wiederhorn, opinion contributor © Getty Images COVID proves clinical trials must proactively recruit people of color In the year since the start of the COVID-19 pandemic and the subsequent death of more than 500,000 Americans, researchers around the world have raced to develop vaccines at an unprecedented pace. But the quest to stop the pandemic in its tracks has collided with a long-standing problem: the lack of diversity in clinical trials. This issue must be addressed and the new federal administration can help. The Centers for Disease Control and Prevention report that Black Americans are 1.1 times as likely as white Americans to contract COVID-19, 2.9 times as likely to end up in the hospital and nearly twice as likely to die from it. Yet the communities hardest hit by illnesses like COVID-19 are also those grossly underrepresented in clinical trials for cures and therapeutics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.